Skip to main content Accessibility help
  • Print publication year: 2013
  • Online publication date: June 2014


Related content

Powered by UNSILO

Suggested reading

Chapron DJ, Sweeney KR, Feig PU, Kramer PA. Influence of advanced age on the disposition of acetazolamide. British Journal of Clinical Pharmacology 1985; 19: 363–371.
Forsythe WI, Owens JR, Toothill C. Effectiveness of acetazolamide in the treatment of carbamazepine-resistant epilepsy in children. Developmental Medicine and Child Neurology 1981; 23: 761–769.
Holowach J, Thurston DL. A clinical evaluation of acetazolamide (Diamox) in the treatment of epilepsy in children. Journal of Pediatrics 1958; 53: 160–171.
Katayama F, Miura H, Takanashi S. Long-term effectiveness and side effects of acetazolamide as an adjunct to other anticonvulsants in the treatment of refractory epilepsies. Brain and Development 2002; 24: 150–154.
Lim LL, Foldvary N, Mascha E, Lee J. Acetazolamide in women with catamenial epilepsy. Epilepsia 2001; 42: 746–749.
Oles KS, Penry K, Cole DLW, Howard G. Use of acetazolamide as an adjunct to carbamazepine in refractory partial seizures. Epilepsia 1989; 30: 74–78.
Reiss WG, Oles KS. Acetazolamide in the treatment of seizures. Annals of Pharmacotherapy 1996; 30: 514–519.
Resor SR, Resor LD. Chronic acetazolamide monotherapy in the treatment of juvenile myoclonic epilepsy. Neurology 1990; 40: 1677–1681.
Soderman P, Hartvig P, Fagerlund C. Acetazolamide excretion into breast milk. British Journal of Clinical Pharmacology 1984; 17: 599–600.
Tawil R, Moxley RT, Griggs RC. Acetazolamide-induced nephro-lithiasis: implications for treatment of neuromuscular disorders. Neurology 1993; 43: 1105–1106.
Vaziri ND, Saiki J, Barton CH, Rajudin M, Ness RL. Hemodialyzability of acetazolamide. South Medical Journal 1980; 73: 422–423.
Watson WA, Garrelts JC, Zinn PD, Garriott JC, McLemore TL, Clementi WA. Chronic acetazolamide intoxication. Clinical Toxicology 1984; 22: 549–563.